Home › Companies › Elanco Animal Health Incorporated › 2025-2026

Elanco Animal Health Incorporated 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Elanco Animal Health Incorporated’s Form 8-K, filed 2026-05-27 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 9Reported items
  • 504Asset managers
  • 4,226Fund votes
  • 2026-05-21Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Elanco Animal Health Incorporated in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Elanco Animal Health Incorporated

These tallies are Elanco Animal Health Incorporated’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-27 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Elanco Animal Health Incorporated — official shareholder meeting results, meeting held 2026-05-21
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Kapila K. Anand 375,459,07191,840,502655,918 --15,365,167 Majority: yes
Elect Director: Paul Herendeen 441,252,05826,575,629127,804 --15,365,167 Majority: yes
Elect Director: Michael Harrington 373,406,33394,421,261127,897 --15,365,167 Majority: yes
Elect Director: Lawrence Kurzius 442,964,89724,863,542127,052 --15,365,167 Majority: yes
Elect Director: Kirk McDonald 440,842,45826,978,663134,370 --15,365,167 Majority: yes
Proposal 2. The shareholders ratified the appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2026, by the votes set forth in the table below. 480,470,6472,611,450238,561 ---- Majority: yes
Proposal 3. The shareholders approved, by non-binding vote, the compensation of Elanco's named executive officers, by the votes set forth in the table below. 383,528,22284,173,798253,471 --15,365,167 Majority: yes

Source: Elanco Animal Health Incorporated, Form 8-K, filed with the SEC on 2026-05-27 — read the filing on EDGAR.

How asset managers voted at the Elanco Animal Health Incorporated 2025-2026 meeting

Each item below shows how the 504 asset managers that disclosed a Elanco Animal Health Incorporated vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Elanco Animal Health Incorporated’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Advisory vote on the compensation of the company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 11 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%AGAINST 18%
FOR: 383,528,222AGAINST: 84,173,798

Elanco Animal Health Incorporated’s own tally for this item (“Proposal 3. The shareholders approved, by non-binding vote, the compensation of Elanco's named executive officers, by the votes set forth in the table below.”): 383,528,222 for, 84,173,798 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 499,449,583 outstanding shares: 77% for, 17% against (94% of the company cast a for/against vote).

The 498 asset managers below cast 78% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 78%AGAINST 22%
FOR: 78.4%AGAINST: 21.5%ABSTAIN: 0.0%NOT VOTED: 0.0%
Largest asset managers voting on “Advisory vote on the compensation of the company's named executive officers.” at Elanco Animal Health Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Dodge & Cox0117,998,184 00Against
Fidelity93,329,59183,976 00For
Vanguard84,611,562185 00For
T. Rowe Price54,244,496457,720 00For
PRIMECAP MANAGEMENT CO/CA/43,001,3070 00For
Winslow Capital Management, LLC33,374,2280 00For
BlackRock31,078,851204,984 00For
Invesco011,858,670 00Against
GEODE CAPITAL MANAGEMENT, LLC11,088,5290 00For
Black Creek Investment Management Inc.10,032,2660 00For
State Street9,622,18811,988 00For
John Hancock9,122,7610 00For
Dimensional7,976,4420 00For
Charles Schwab7,396,1710 00For
PRIMECAP Odyssey Funds6,081,3020 00For
FULLER & THALER ASSET MANAGEMENT, INC.5,648,9040 00For
Capital Group5,572,6510 00For
Allspring4,749,4170 00For
Bridge Builder Trust4,679,9780 00For
Clearbridge Investments, LLC4,280,7890 00For
New York Life4,073,75762,244 00For
Capitol Series Trust3,833,8000 00For
Federated Hermes3,421,39269,609 00For
BARROW HANLEY MEWHINNEY & STRAUSS LLC3,475,2830 00For
JUPITER ASSET MANAGEMENT LTD3,427,5970 00For

Showing the 25 largest of 498 asset managers. See all 498 in the interactive database.

2. RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2026.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 4 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 480,470,647AGAINST: 2,611,450

Elanco Animal Health Incorporated’s own tally for this item (“Proposal 2. The shareholders ratified the appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2026, by the votes set forth in the table below.”): 480,470,647 for, 2,611,450 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 499,449,583 outstanding shares: 96% for, 0.6% against (97% of the company cast a for/against vote).

The 110 asset managers below cast 99.9% of the shares they voted on this item FOR (288,492,324 for, 129,770 against).

FOR 99.9%
FOR: 288,492,324 (99.9%)AGAINST: 129,770 (0.0%)ABSTAIN: 82,173 (0.0%)NOT VOTED: 419 (0.0%)
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING” at Elanco Animal Health Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard80,608,15655,258 00For
Dodge & Cox53,024,2530 00For
Fidelity47,607,8160 00For
BlackRock21,297,8320 00For
T. Rowe Price19,225,8590 00For
Dimensional6,874,2620 00For
PRIMECAP Odyssey Funds6,081,3020 00For
Invesco5,773,0170 00For
Bridge Builder Trust4,679,9780 00For
New York Life4,136,0010 00For
Capitol Series Trust3,833,8000 00For
Charles Schwab3,464,6240 00For
John Hancock3,277,4750 00For
Legg Mason2,500,0000 00For
Jackson National2,498,1570 00For
Capital Group2,164,2930 00For
Allspring2,027,2400 00For
TIAA1,716,5850 00For
Prudential/PGIM1,583,3210 00For
Federated Hermes1,298,6290 00For
NEW ECONOMY FUND1,147,9890 00For
Empower993,2350 00For
AIG/SunAmerica907,5100 00For
Equitable886,3950 00For
Nuveen776,5890 00For

Showing the 25 largest of 110 asset managers. See all 110 in the interactive database.

3. Election of two Class I director nominees and three Class II director nominees: Class I Nominees: Kapila Anand

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 5 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%AGAINST 20%
FOR: 375,459,071AGAINST: 91,840,502

Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Kapila K. Anand”): 375,459,071 for, 91,840,502 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 499,449,583 outstanding shares: 75% for, 18% against (94% of the company cast a for/against vote).

The 109 asset managers below cast 79% of the shares they voted on this item FOR (227,770,641 for, 60,795,821 against).

FOR 79%AGAINST 21%
FOR: 227,770,641 (78.9%)AGAINST: 60,795,821 (21.1%)ABSTAIN: 82,174 (0.0%)NOT VOTED: 419 (0.0%)
Largest asset managers voting on “Election of two Class I director nominees and three Class II director nominees: Class I Nominees: Kapila Anand” at Elanco Animal Health Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard80,607,95255,461 10For
Dodge & Cox053,024,253 00Against
Fidelity47,607,8160 00For
BlackRock21,297,8320 00For
T. Rowe Price19,225,8590 00For
Dimensional06,874,262 00Against
PRIMECAP Odyssey Funds6,081,3020 00For
Invesco5,773,0170 00For
Bridge Builder Trust4,679,9780 00For
New York Life4,136,0010 00For
Capitol Series Trust3,833,8000 00For
Charles Schwab3,464,6240 00For
John Hancock3,162,137115,338 00For
Legg Mason2,500,0000 00For
Jackson National2,413,84384,314 00For
Capital Group2,164,2930 00For
Allspring2,027,2400 00For
TIAA1,716,5850 00For
Prudential/PGIM1,578,5404,781 00For
Federated Hermes1,298,6290 00For
NEW ECONOMY FUND1,147,9890 00For
Empower993,2350 00For
AIG/SunAmerica907,5100 00For
Equitable886,3950 00For
Nuveen776,5890 00For

Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.

4. Election of two Class I director nominees and three Class II director nominees: Class I Nominees: Paul Herendeen

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 5 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 441,252,058AGAINST: 26,575,629

Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Paul Herendeen”): 441,252,058 for, 26,575,629 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 499,449,583 outstanding shares: 88% for, 5% against (94% of the company cast a for/against vote).

The 109 asset managers below cast 97% of the shares they voted on this item FOR (280,795,042 for, 7,771,421 against).

FOR 97%
FOR: 280,795,042 (97.3%)AGAINST: 7,771,421 (2.7%)ABSTAIN: 82,173 (0.0%)NOT VOTED: 419 (0.0%)
Largest asset managers voting on “Election of two Class I director nominees and three Class II director nominees: Class I Nominees: Paul Herende” at Elanco Animal Health Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard80,608,10055,314 00For
Dodge & Cox53,024,2530 00For
Fidelity47,607,8160 00For
BlackRock21,297,8320 00For
T. Rowe Price19,225,8590 00For
Dimensional06,874,262 00Against
PRIMECAP Odyssey Funds6,081,3020 00For
Invesco5,773,0170 00For
Bridge Builder Trust4,679,9780 00For
New York Life4,136,0010 00For
Capitol Series Trust3,833,8000 00For
Charles Schwab3,464,6240 00For
John Hancock3,162,137115,338 00For
Legg Mason2,500,0000 00For
Jackson National2,413,84384,314 00For
Capital Group2,164,2930 00For
Allspring2,027,2400 00For
TIAA1,716,5850 00For
Prudential/PGIM1,578,5404,781 00For
Federated Hermes1,298,6290 00For
NEW ECONOMY FUND1,147,9890 00For
Empower993,2350 00For
AIG/SunAmerica907,5100 00For
Equitable886,3950 00For
Nuveen776,5890 00For

Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.

5. Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Kirk McDonald

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 6 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 440,842,458AGAINST: 26,978,663

Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Kirk McDonald”): 440,842,458 for, 26,978,663 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 499,449,583 outstanding shares: 88% for, 5% against (94% of the company cast a for/against vote).

The 109 asset managers below cast 97% of the shares they voted on this item FOR (280,795,042 for, 7,771,421 against).

FOR 97%
FOR: 280,795,042 (97.3%)AGAINST: 7,771,421 (2.7%)ABSTAIN: 82,173 (0.0%)NOT VOTED: 419 (0.0%)
Largest asset managers voting on “Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Kirk McDona” at Elanco Animal Health Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard80,608,10055,314 00For
Dodge & Cox53,024,2530 00For
Fidelity47,607,8160 00For
BlackRock21,297,8320 00For
T. Rowe Price19,225,8590 00For
Dimensional06,874,262 00Against
PRIMECAP Odyssey Funds6,081,3020 00For
Invesco5,773,0170 00For
Bridge Builder Trust4,679,9780 00For
New York Life4,136,0010 00For
Capitol Series Trust3,833,8000 00For
Charles Schwab3,464,6240 00For
John Hancock3,162,137115,338 00For
Legg Mason2,500,0000 00For
Jackson National2,413,84384,314 00For
Capital Group2,164,2930 00For
Allspring2,027,2400 00For
TIAA1,716,5850 00For
Prudential/PGIM1,578,5404,781 00For
Federated Hermes1,298,6290 00For
NEW ECONOMY FUND1,147,9890 00For
Empower993,2350 00For
AIG/SunAmerica907,5100 00For
Equitable886,3950 00For
Nuveen776,5890 00For

Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.

6. Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Lawrence Kurzius

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 5 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 442,964,897AGAINST: 24,863,542

Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Lawrence Kurzius”): 442,964,897 for, 24,863,542 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 499,449,583 outstanding shares: 89% for, 5% against (94% of the company cast a for/against vote).

The 109 asset managers below cast 97% of the shares they voted on this item FOR (280,795,047 for, 7,771,416 against).

FOR 97%
FOR: 280,795,047 (97.3%)AGAINST: 7,771,416 (2.7%)ABSTAIN: 82,173 (0.0%)NOT VOTED: 419 (0.0%)
Largest asset managers voting on “Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Lawrence Ku” at Elanco Animal Health Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard80,608,10555,309 00For
Dodge & Cox53,024,2530 00For
Fidelity47,607,8160 00For
BlackRock21,297,8320 00For
T. Rowe Price19,225,8590 00For
Dimensional06,874,262 00Against
PRIMECAP Odyssey Funds6,081,3020 00For
Invesco5,773,0170 00For
Bridge Builder Trust4,679,9780 00For
New York Life4,136,0010 00For
Capitol Series Trust3,833,8000 00For
Charles Schwab3,464,6240 00For
John Hancock3,162,137115,338 00For
Legg Mason2,500,0000 00For
Jackson National2,413,84384,314 00For
Capital Group2,164,2930 00For
Allspring2,027,2400 00For
TIAA1,716,5850 00For
Prudential/PGIM1,578,5404,781 00For
Federated Hermes1,298,6290 00For
NEW ECONOMY FUND1,147,9890 00For
Empower993,2350 00For
AIG/SunAmerica907,5100 00For
Equitable886,3950 00For
Nuveen776,5890 00For

Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.

7. Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Michael Harrington

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-21.

Combines 5 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%AGAINST 20%
FOR: 373,406,333AGAINST: 94,421,261

Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Michael Harrington”): 373,406,333 for, 94,421,261 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 499,449,583 outstanding shares: 75% for, 19% against (94% of the company cast a for/against vote).

The 109 asset managers below cast 79% of the shares they voted on this item FOR (227,484,486 for, 61,081,977 against).

FOR 79%AGAINST 21%
FOR: 227,484,486 (78.8%)AGAINST: 61,081,977 (21.2%)ABSTAIN: 82,173 (0.0%)NOT VOTED: 419 (0.0%)
Largest asset managers voting on “Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Michael Har” at Elanco Animal Health Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard80,578,31385,101 00For
Dodge & Cox053,024,253 00Against
Fidelity47,607,8160 00For
BlackRock21,297,8320 00For
T. Rowe Price19,225,8590 00For
Dimensional06,874,262 00Against
PRIMECAP Odyssey Funds6,081,3020 00For
Invesco5,773,0170 00For
Bridge Builder Trust4,679,9780 00For
New York Life4,136,0010 00For
Capitol Series Trust3,833,8000 00For
Charles Schwab3,464,6240 00For
John Hancock3,162,137115,338 00For
Legg Mason2,500,0000 00For
Jackson National2,413,84384,314 00For
Capital Group2,164,2930 00For
Allspring2,027,2400 00For
TIAA1,716,5850 00For
Prudential/PGIM1,578,5404,781 00For
Federated Hermes1,298,6290 00For
NEW ECONOMY FUND1,147,9890 00For
Empower993,2350 00For
AIG/SunAmerica907,5100 00For
Equitable886,3950 00For
Nuveen776,5890 00For

Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.

8. Advisory vote on the compensation of the company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-16 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).

53.5% Majority: yes · of votes cast

FOR 53.5%AGAINST 46.5%
FOR: 244,532,049AGAINST: 212,491,837

Elanco Animal Health Incorporated’s own tally for this item (“Proposal 3. The shareholders approved, by non-binding vote, the compensation of Elanco's named executive officers, by the votes set forth in the table below.”): 244,532,049 for, 212,491,837 against, per its Form 8-K filed 2025-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 499,449,583 outstanding shares: 49.0% for, 43% against (92% of the company cast a for/against vote).

The 2 asset managers below cast 100% of the shares they voted on this item FOR (43,040 for, 0 against).

FOR 100%
FOR: 43,040 (100.0%)
Largest asset managers voting on “Advisory vote on the compensation of the company's named executive officers.” at Elanco Animal Health Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
GLENMEDE FUND INC27,5400 00For
OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC15,5000 00For

9. Advisory vote on the frequency with which shareholders vote on the compensation of the company's named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-05-16 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).

— fund support · no official result

ONE YEAR 64%3 YEARS 36%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

ONE YEAR: 27,540 (64.0%)3 YEARS: 15,500 (36.0%)
Largest asset managers voting on “Advisory vote on the frequency with which shareholders vote on the compensation of the company's named executi” at Elanco Animal Health Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
GLENMEDE FUND INC00 00One Year
OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC00 003 Years

Largest Elanco Animal Health Incorporated shareholders voting in 2025-2026

Ranked by the number of Elanco Animal Health Incorporated shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 499,449,583 shares outstanding at the time of that meeting.

Top Elanco Animal Health Incorporated shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Dodge & Cox 23.63%
2Fidelity 18.70%
3Vanguard 16.94%
4T. Rowe Price 10.95%
5PRIMECAP MANAGEMENT CO/CA/ 8.61%
6Winslow Capital Management, LLC 6.68%
7BlackRock 6.26%
8Invesco 2.37%
9GEODE CAPITAL MANAGEMENT, LLC 2.22%
10Black Creek Investment Management Inc. 2.01%

Reported Elanco Animal Health Incorporated ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Elanco Animal Health Incorporated beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
Dodge & Cox 13.80% 13G
FMR LLC 10.45% DEF14A
FMR (Fidelity) 10.20% 13F
Vanguard Group 9.62% 13F
BlackRock 9.54% 13F
PRIMECAP MANAGEMENT CO/CA/ 9.18% 13G
T. Rowe Price Investment Management, Inc. 6.32% DEF14A
Dimensional Fund Advisors LP 5.02% DEF14A
State Street 3.07% 13F
Morgan Stanley 1.66% 13F

Percentages above are of 499,449,583 shares outstanding, as reported by Elanco Animal Health Incorporated on its Form 10-Q dated 2026-05-01 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Elanco Animal Health Incorporated’s 10-Q dated 2026-05-01. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Elanco Animal Health Incorporated's shareholder meeting held 2026-05-21, in the 2025-2026 proxy season, 504 asset managers reported how they voted in their SEC Form N-PX filings, covering 4,226 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory vote on the compensation of the company's named executive officers. — FOR was 82% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Elanco Animal Health Incorporated's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-27.

Elanco Animal Health Incorporated proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).